Get all your news in one place.
100's of premium titles.
One app.
Start reading
WEKU
WEKU
Health
Jon Hamilton

Is lecanemab the Alzheimer's drug that will finally make a difference?

In a large study, experimental drug lecanemab was able to slow down Alzheimer's, but not stop it. Some researchers think the drug will become the first to help many patients; others have questions. (Cemile Bingol/Getty Images)

A drug that offers a small benefit to Alzheimer's patients is making a big splash with doctors who treat the disease.

The drug, a monoclonal antibody called lecanemab, dominated last week's Clinical Trials on Alzheimer's Disease meeting in San Francisco.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.